Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents

Detalhes bibliográficos
Autor(a) principal: Gouveia, TIA
Data de Publicação: 2023
Outros Autores: Gorito, AM, Cristóvão, MB, Pereira, VJ, Crespo, J, Alves, A, Pereira, MFR, Ribeiro, ARL, Silva, AMT, Santos, MSF
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/154325
Resumo: Over the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process.
id RCAP_6afa90551d741c22bcf5b202ddbd0f84
oai_identifier_str oai:repositorio-aberto.up.pt:10216/154325
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluentsOver the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process.American Medical Association20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10216/154325eng0098-74841538-359810.1016/j.jenvman.2023.119314Gouveia, TIAGorito, AMCristóvão, MBPereira, VJCrespo, JAlves, APereira, MFRRibeiro, ARLSilva, AMTSantos, MSFinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T12:58:42Zoai:repositorio-aberto.up.pt:10216/154325Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:30:51.181817Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
title Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
spellingShingle Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
Gouveia, TIA
title_short Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
title_full Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
title_fullStr Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
title_full_unstemmed Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
title_sort Nanofiltration combined with ozone-based processes for the removal of antineoplastic drugs from wastewater effluents
author Gouveia, TIA
author_facet Gouveia, TIA
Gorito, AM
Cristóvão, MB
Pereira, VJ
Crespo, J
Alves, A
Pereira, MFR
Ribeiro, ARL
Silva, AMT
Santos, MSF
author_role author
author2 Gorito, AM
Cristóvão, MB
Pereira, VJ
Crespo, J
Alves, A
Pereira, MFR
Ribeiro, ARL
Silva, AMT
Santos, MSF
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Gouveia, TIA
Gorito, AM
Cristóvão, MB
Pereira, VJ
Crespo, J
Alves, A
Pereira, MFR
Ribeiro, ARL
Silva, AMT
Santos, MSF
description Over the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process.
publishDate 2023
dc.date.none.fl_str_mv 2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/154325
url https://hdl.handle.net/10216/154325
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0098-7484
1538-3598
10.1016/j.jenvman.2023.119314
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv American Medical Association
publisher.none.fl_str_mv American Medical Association
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135617684078592